InvestorsHub Logo
Followers 4
Posts 227
Boards Moderated 0
Alias Born 05/03/2018

Re: None

Thursday, 08/02/2018 9:45:13 AM

Thursday, August 02, 2018 9:45:13 AM

Post# of 425677
Question for anyone reading... if you look at Anchor the trial was only over 12 weeks and now in R-IT obviously much longer over a number of years. I was curious if the mentioned side effects of bleeding by Dr Budoff could happen more over a longer period? I know there have been 3 month safety interval checks by the DMC , does that mean this safety risk accrued over a longer period is fully mitigated or not known at this point?

also can someone remind me what the baseline TG is in R-IT as compared to Anchor.

thanks in advance
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News